The hsa-miR-582-5p inhibits metastasis of prostate cancer by repressing multiple components of TGF-β signalling, resulting in the inactivation of TGF-β signalling (Gordanpour et al., 2012) (Huang et al., 2019). The gene discussed is TGFB1; the disease is prostate carcinoma.